Nicox S.A. (OTCMKTS:NICXF – Get Free Report)’s stock price passed below its 50 day moving average during trading on Monday . The stock has a 50 day moving average of $0.25 and traded as low as $0.25. Nicox shares last traded at $0.25, with a volume of 500 shares changing hands.
Nicox Stock Performance
The business has a 50 day moving average of $0.25 and a 200 day moving average of $0.31.
Nicox Company Profile
Nicox SA operates as an ophthalmology company in France and internationally. The company develops solutions to maintain vision and improve ocular health. Its lead product candidate is NCX 470, a novel nitric oxide-donating bimatoprost eye drop for lowering intraocular pressure in patients with open-angle glaucoma or ocular hypertension, which is in Phase 3 clinical trial.
Featured Articles
- Five stocks we like better than Nicox
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Energy Transfer: Powering Data With Dividends and Diversification
- P/E Ratio Calculation: How to Assess Stocks
- Qualcomm Stock Is Coiling for a Breakout
- What is a support level?
- Is Alphabet Too Cheap to Ignore After Its Recent Correction?
Receive News & Ratings for Nicox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nicox and related companies with MarketBeat.com's FREE daily email newsletter.
